Showing results (351-360 of 994) with videos related to
Sort By:
Pageof 100
Nature Reviews. Disease Primers|August 25, 2022
Multiple system atrophyWerner Poewe, Iva Stankovic, Glenda Halliday, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2010
Long-term antidyskinetic efficacy of amantadine in Parkinson's diseaseElisabeth Wolf, Klaus Seppi, Regina Katzenschlager, et al.Parkinsonism & Related Disorders|August 31, 2015
Large-scale TUBB4A mutational screening in isolated dystonia and controlsMichael Zech, Sylvia Boesch, Angela Jochim, et al.Brain Research. Cognitive Brain Research|July 26, 2003
Medial temporal lobe activation during semantic language processing: fMRI findings in healthy left- and right-handersLisa Bartha, Christian Brenneis, Michael Schocke, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2010
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD studyAnthony H V Schapira, Stefan Albrecht, Paolo Barone, et al.Journal of Neurology|June 29, 2018
Autonomic function testing in Friedreich's ataxiaElisabetta Indelicato, Alessandra Fanciulli, Jean-Pierre Ndayisaba, et al.Parkinsonism & Related Disorders|December 22, 2019
Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyPhilipp Mahlknecht, Heike Stockner, Kathrin Marini, et al.Annals of Neurology|July 23, 2005
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndromeChristoph Schmidauer, Martin Sojer, Klaus Seppi, et al.Pharmacoeconomics - Open|October 31, 2025
Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology AssessmentTobias Sydendal Grand, Shijie Ren, Praveen Thokala, et al.Neuro-Degenerative Diseases|May 22, 2013
Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based studyPhilipp Mahlknecht, Klaus Seppi, Heike Stockner, et al.Pageof 100